What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-03-02 compared with 2025-03-27 · 43 added, 15 removed, 0 unchanged (100% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY,

RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is listed on

The Nasdaq Stock Market LLC under the symbol “HROW” and the Notes are listed on The Nasdaq Stock Market LLC under the symbols

“HROWL” and “HROWM.”

As of February 28, 2025, there

were approximately 57 stockholders of record (excluding an indeterminable number of stockholders whose shares are held in street or “nominee”

name) of our common stock.

We have not paid any dividends

on our common stock since our inception and do not expect to pay dividends on our common stock in the foreseeable future.

Purchase of Equity Securities

We did not purchase any of our

equity securities during the fourth quarter of 2024.

Recent Sales of Unregistered Securities

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Information for Common Stock

common stock is listed on The Nasdaq Stock Market LLC under the symbol “HROW”.

common stock is traded on The Nasdaq Stock Market LLC and is a component of both the Nasdaq Composite Index and the Nasdaq Biotechnology

The following graph shows cumulative total stockholder return (i.e., price change plus reinvestment of dividends) on our common

stock over the period commencing December 31, 2020 and ending on December 31, 2025, to that of the total return for the Nasdaq Composite

Index and the Nasdaq Biotechnology Index, assuming an investment of $100 on December 31, 2020.

The stock performance shown on the graph

represents historical stock performance and is not necessarily indicative of future stock price performance

OF 5 YEAR CUMULATIVE TOTAL RETURN*

Harrow Inc., the NASDAQ Composite Index and the NASDAQ Biotechnology Index

Invested on 12/31/2020 in stock or index, including reinvestment of dividends.

year ending December 31.

graph and related information is furnished under this Part II, Item 5 of this Annual Report on Form 10-K and shall not be deemed “soliciting

material” or be “filed” with the SEC and shall not be incorporated by reference into any filing we make under the Securities

Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective

of any general incorporation by reference language in such filing.

of February 25, 2026, there were approximately 56 stockholders of record (excluding an indeterminable number of stockholders whose

shares are held in street or “nominee” name) of our common stock.

have not paid any dividends on our common stock since our inception and do not expect to pay dividends on our common stock in the foreseeable

Authorized for Issuance under Equity Compensation Plans

information required by this item will be set forth in the definitive proxy statement we will file in connection with our 2026 Annual

Meeting of Stockholders and is incorporated by reference herein.

Purchases of Equity Securities

the three months ended December 31, 2025, the Company withheld shares of common stock to satisfy employee minimum statutory tax withholding

obligations payable upon the vesting of restricted stock, as follows:

Total Number of

Shares Purchased (a)

Weighted Average

Price Paid per Share

Part of Publicly

Announced Plans

or Programs (b)

Number of Shares

That May Yet Be

October1 – October 31

November 1 – November 30

December 1 – December 31

shares withheld to satisfy the payment of tax obligations related to the vesting of restricted

stock awards.

had no publicly announced repurchase programs for shares of our common stock during the year

ended December 31, 2025.

Sales of Unregistered Securities

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity